Lv11
40 积分 2025-02-23 加入
Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China
2小时前
已完结
Global epidemiology of epithelial ovarian cancer
9小时前
已完结
皖公网安备34019202002308
